Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0030 Transporter Info
Gene Name	SLCO1B3
Transporter Name	Organic anion transporting polypeptide 1B3
Gene ID	28234
UniProt ID	Q9NPD5

Post-Translational Modification of This DT
Overview of SLCO1B3 Modification Sites with Functional and Structural Information
Sequence	M D Q H Q H L N K T A E S A S S E K K K T R R C N G F K M F L A A L S F S Y I A K A L G G I I M K I S I T Q I E R R F D I S S S L A G L I D G S F E I G N L L V I V F V S Y F G S K L H R P K L I G I G C L L M G T G S I L T S L P H F F M G Y Y R Y S K E T H I N P S E N S T S S L S T C L I N Q T L S F N G T S P E I V E K D C V K E S G S H M W I Y V F M G N M L R G I G E T P I V P L G I S Y I D D F A K E G H S S L Y L G S L N A I G M I G P V I G F A L G S L F A K M Y V D I G Y V D L S T I R I T P K D S R W V G A W W L G F L V S G L F S I I S S I P F F F L P K N P N K P Q K E R K I S L S L H V L K T N D D R N Q T A N L T N Q G K N V T K N V T G F F Q S L K S I L T N P L Y V I F L L L T L L Q V S S F I G S F T Y V F K Y M E Q Q Y G Q S A S H A N F L L G I I T I P T V A T G M F L G G F I I K K F K L S L V G I A K F S F L T S M I S F L F Q L L Y F P L I C E S K S V A G L T L T Y D G N N S V A S H V D V P L S Y C N S E C N C D E S Q W E P V C G N N G I T Y L S P C L A G C K S S S G I K K H T V F Y N C S C V E V T G L Q N R N Y S A H L G E C P R D N T C T R K F F I Y V A I Q V I N S L F S A T G G T T F I L L T V K I V Q P E L K A L A M G F Q S M V I R T L G G I L A P I Y F G A L I D K T C M K W S T N S C G A Q G A C R I Y N S V F F G R V Y L G L S I A L R F P A L V L Y I V F I F A M K K K F Q G K D T K A S D N E R K V M D E A N L E F L N N G E H F V P S A G T D S K T C N L D M Q D N A A A N
PTM type	X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLCO1B3			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	134
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLCO1B3 Asparagine 134 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLCO1B3			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	145
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLCO1B3 Asparagine 145 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLCO1B3			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	151
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLCO1B3 Asparagine 151 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLCO1B3			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	445
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLCO1B3 Asparagine 445 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLCO1B3			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	503
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLCO1B3 Asparagine 503 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLCO1B3			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	516
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLCO1B3 Asparagine 516 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing the membrane expression and transport activity of SLCO1B3			[2]
Role of PTM	Protein Activity Modulation
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at SLCO1B3 have been reported to decrease its membrane expression and transport activity.
Phosphorylation
Serine	12 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLCO1B3			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	15
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 15 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLCO1B3			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	16
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 16 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLCO1B3			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	205
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 205 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLCO1B3			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	206
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 206 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLCO1B3			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	228
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 228 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLCO1B3			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	293
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 293 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLCO1B3			[3] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	295
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 295 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLCO1B3			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	328
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 328 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLCO1B3			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	370
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 370 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLCO1B3			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	372
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 372 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLCO1B3			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	683
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 683 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLCO1B3			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	688
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Serine 688 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLCO1B3			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	308
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Threonine 308 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLCO1B3			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	319
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Threonine 319 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLCO1B3			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	323
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Threonine 323 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLCO1B3			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	382
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Threonine 382 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLCO1B3			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	385
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Threonine 385 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLCO1B3			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	388
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Threonine 388 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLCO1B3			[9]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	362
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Tyrosine 362 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLCO1B3			[9]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	367
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 Tyrosine 367 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing the activity of SLCO1B3			[12]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	[3H]CCK-8	Results for Drug	Decreasing the transport of [3H]CCK-8
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Material(s)	Human hepatocytes
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLCO1B3 have been reported to decrease its transport activity.
Ubiquitination
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Significantly decreased the maximal transport velocity (Vmax) of transporter			[13]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	[3H]CCK-8	Results for Drug	Decreasing the transport of [3H]CCK-8
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLCO1B3 have been reported to significantly decrease its maximal transport velocity (Vmax).

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SO1B3_HUMAN)
2	Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease. Liver Int. 2017 Jul;37(7):1074-1081.
3	In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
4	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
5	Large-scale proteome quantification of hepatocellular carcinoma tissues by a three-dimensional liquid chromatography strategy integrated with sample preparation. J Proteome Res. 2014 Aug 1;13(8):3645-54.
6	Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. Hepatol Res. 2017 Dec;47(13):1469-1483.
7	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8	Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
9	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
10	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
11	Systematic analysis of protein phosphorylation networks from phosphoproteomic data. Mol Cell Proteomics. 2012 Oct;11(10):1070-83.
12	Novel mechanism of impaired function of organic anion-transporting polypeptide 1B3 in human hepatocytes: post-translational regulation of OATP1B3 by protein kinase C activation. Drug Metab Dispos. 2014 Nov;42(11):1964-70.
13	Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner. PLoS One. 2017 Nov 6;12(11):e0186924.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence